Clinical trials recruiting for Bevacizumab
3
Recruiting trials
0
US states with sites
1
Countries
0%
Accept healthy volunteers
Phase breakdown
Phase 2 2Not applicable 1
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Befotertinib combined Bevacizumab | 1 |
| Befotertinib combined platinum-based double chemotherapy | 1 |
| Bevacizumab | 1 |
| Cadonilimab | 1 |
| Trifluridine/tipiracil (TAS-102) plus bevacizumab | 1 |
Self-screener
Recruiting trials
- Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases
- Low-dose Trifluridine/Tipiracil With Bevacizumab in mCRC
- Neoadjuvant Befotertinib Combined Bevacizumab or Platinum-based Double Chemotherapy for Resectable Locally-advanced EGFR Mutation-positive Non-Small Cell Lung Cancer
Related conditions
Trials recruiting for Bevacizumab often also study these conditions. Each links to its own recruiting-trial list.
Lung cancer 2180Non-small cell lung cancer 507Locally Advanced Non-Small Cell Lung Cancer 11Hepatocellular carcinoma 51EGFR 6Colorectal cancer 1359Colo-rectal Cancer 26Cadonilimab 4
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for Bevacizumab trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.